Results 281 to 290 of about 413,528 (329)

Derivation and Definitions of Clinical Study Variables for Multiple Long Term Conditions in Patients with Chronic Obstructive Pulmonary Disease: Protocol for a Modified Delphi Methods and Consensus Study on Behalf of the International Cardiovascular and Respiratory Alliance. [PDF]

Pragmat Obs Res
Joseph T, Bhutani M, Couper A, Pullen R, Nadarajah R, Alves L, Montero-Arias MF, Al-Lehebi R, Berg DD, Hawkins NM, Hurst JR, Jenkins CR, Kaplan A, Kocks JWH, Kostikas K, Lam CSP, Lapperre TS, Rhee CK, Sattar N, Stolz D, Tse G, Winders T, Price D, Gale CP.   +23 more
europepmc   +1 more source

Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe

ESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.
Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Egidio Imbalzano, Antoni Bayes‐Genis, Ewa Jankowska, Michele Senni, Marco Metra, Ovidiu Chioncel, Andrew J. S. Coats, Giuseppe M. C. Rosano   +11 more
wiley   +1 more source

Characteristics and Survival Among Patients With Cardiogenic Shock Undergoing Mitral Transcatheter Edge-to-Edge Repair. [PDF]

JACC Adv
Haghighat L, Cheng R, Barnett CF, Brusca SB, Park JG, Carnicelli AP, Nguyen AH, Nair RM, Morrow DA, O'Brien CG.   +9 more
europepmc   +1 more source

President's page: The American College of Cardiology and Ethics in Cardiovascular Medicine

Journal of the American College of Cardiology, 1989
openaire   +1 more source

Correction: CUGBP Elav-like family member 4 promotes cardiac remodeling through inhibition of FMO2. [PDF]

BMC Cardiovasc Disord
Zhang X, Wang J, Li J, Lu Q, Xu W, Zhuang J, Tang B.   +6 more
europepmc   +1 more source

Sarcopenia in atrial fibrillation: a risk factor for adverse outcomes in a UK Biobank study. [PDF]

Europace
Kim HJ, Yang PS, Park H, Kim D, Bae HJ, Lee CH, Son JW, Kim U, Joung B.   +8 more
europepmc   +1 more source

Takotsubo cardiomyopathy during armed conflict: A case series

ESC Heart Failure, Volume 12, Issue 2, Page 1494-1498, April 2025.
Sharon Bruoha, Artyom Star, Gili Givaty, Michael Shilo, Michael Friger, Vladimir Chitoroga, Hezzy Shmueli, Yigal Abramowitz, Elad Asher, Jamal Jafari, Vladimir Shlyakhover, Doron Zahger, Moti Haim, Chaim Yosefy   +13 more
wiley   +1 more source

An old drug in a new era: digitoxin in the spotlight after DIGIT-HF. [PDF]

Eur Heart J Cardiovasc Pharmacother
Gragnano F, Galli M, Calabrò P, Dobrev D.   +3 more
europepmc   +1 more source

Electrophysiological characteristics of Purkinje potentials and the conduction system in premature ventricular contractions triggering ventricular fibrillation after myocardial infarction. [PDF]

Europace
Hayashi T, Komatsu Y, Kowase S, Fukamizu S, Nagashima K, Takahashi M, Mori H, Tao S, Yamamoto S, Onishi Y, Yagishita A, Ohashi J, Fukunaga M, Mizukami A, Inaba O, Kasai Y, Kitai T, Yamashita K, Tokudome D, Hashiguchi N, Nakamura T, Sato K, Sahara N, Minami K, Ugata Y, Asano T, Kato R, Sasano T, Fujita H.   +28 more
europepmc   +1 more source

Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention

ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou, Yu Wu, Guoran Li, Yongwen Qin, Man Qi, Zhitao Jin   +5 more
wiley   +1 more source